SIETES :: 93212 citas

Resultados de la búsqueda por LEGUMBRES REFINAR BÚSQUEDA

1.

DeSalvo KB, Olson R, Casavale KO. Dietary guidelines for Americans. JAMA 2016;315:457-8. [Ref.ID 100020]

2.

Mozaffarian D, Ludwig DS. The 2015 US dietary guidelines: lifting the ban on total dietary fat. JAMA 2015;313:2421-2. [Ref.ID 99229]

3.

4.

Li S, Flint A, Pai JK, Forman JP, Hu FB, Willett WC, Rexrode KM, Mukamal KJ, Rimm EB. Dietary fiber intake and mortality among survivors of myocardial infarction: prospective cohort study. BMJ 2014;348:g2659. [Ref.ID 97537]

5.

6.

Karppi J, Laukkanen JA, Sivenius J, Ronkainen K, Kurl S. Serum lycopene decreases the risk of stroke in men. A population-based follow-up study. Neurology 2012;79:1540-7. [Ref.ID 93141]

7.

Aune D, Chan DSM, Lau R, Vieira R, Greenwood DC, Kampman E, Norat T. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 2011;343:1082. [Ref.ID 91853]

8.

Anónimo. Fibre and prevention of chronic diseases. BMJ 2011;343:1075. [Ref.ID 91852]

9.

Sayburn A. Eating "5 a day" provides tittle protections against cancer. BMJ 2010;340:830. [Ref.ID 88337]

10.

Nyirenda MJ, Tang JI, Padfield PL, Seckl JR. Hyperkalaemia. BMJ 2009;339:1019-24. [Ref.ID 86996]

11.

Djoussé L, Driver JA, Gaziano JM. Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA 2009;302:394-400. [Ref.ID 86293]

12.

McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, Kazmi K, Yusuf S, for the INTERHEART study investigators. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008;372:224-33. [Ref.ID 83625]

13.

Lind L. Apolipoprotein B/A1 and risk of cardiovascular disease. Lancet 2008;372:185-6. [Ref.ID 83619]

14.

Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, Holden A, De Bacquer D, Collier T, De Backer G, Faergeman O, on behalf of EUROACTION Study Group. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008;371:1999-2012. [Ref.ID 83251]

15.

Tonks A. A spoonful of antigen. BMJ 2007;335:180-2. [Ref.ID 80700]

16.

López AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57. [Ref.ID 77046]

17.

Danaei G, Hoom SV, López AD, Murray CJL, Ezzati M, and the Comparative Risk Assessment collaborating group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005;366:1784-93. [Ref.ID 75487]

18.

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. [Ref.ID 71323]

19.

Ezzati M. How can cross-country research on health risks strengthen interventions? Lessons from INTERHEART. Lancet 2004;364:912-4. [Ref.ID 71309]

20.

Concato J, Horwitz RI. Observational versus randomised trial evidence. Authors' reply. Lancet 2004;364:757. [Ref.ID 71214]